Gregor Diagnostics

A molecular diagnostics company focused on developing a new screening test for prostate cancer.

About

2016

Madison, Wisconsin

Healthcare

Gregor Diagnostics is a molecular diagnostics company developing a revolutionary new screening test for prostate cancer.

Funding

$6.9 million

Undisclosed

First Round Capital, Healthcare Wildcatters, Wisconsin Alumni Research Foundation, Green Park & Golf Ventures

Steven Weinstein: CEO at Gregor Diagnostics. Former Neuroscience Product Development Innovation Lead at Genentech.

Tobias Zutz: Founder & CTO of Gregor Diagnostics. Former Senior Research Associate at Exact Sciences.

Duncan Whitney: Chief Scientific Officer at Gregor Diagnostics. Former Head of Early Detection Lung Cancer Initiative at Johnson & Johnson.